Volume 66, Issue 6, Pages (December 2014)

Slides:

Advertisements

Similar presentations

Volume 58, Issue 5, Pages (November 2010)

Advertisements

Volume 64, Issue 5, Pages (November 2013)

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

European Urology Focus

Volume 63, Issue 2, Pages (February 2013)

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 69, Issue 1, Pages (January 2016)

Volume 73, Issue 5, Pages (May 2018)

Volume 64, Issue 3, Pages (September 2013)

Volume 52, Issue 3, Pages (September 2007)

Prostate Cancer Epidemic in Sight?

Volume 58, Issue 1, Pages (July 2010)

John P. Mulhall, Francesco Montorsi European Urology

Volume 64, Issue 5, Pages (November 2013)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 71, Issue 1, Pages 1-3 (January 2017)

Volume 66, Issue 4, Pages (October 2014)

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 56, Issue 2, Pages (August 2009)

Volume 66, Issue 3, Pages (September 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 50, Issue 4, Pages (October 2006)

Volume 67, Issue 6, Pages (June 2015)

Volume 54, Issue 6, Pages (December 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 2, Pages (August 2009)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Counselling the Prostate Cancer Patient

Volume 64, Issue 6, Pages (December 2013)

Volume 52, Issue 2, Pages (August 2007)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 59, Issue 3, Pages e7-e8 (March 2011)

Volume 53, Issue 2, Pages (February 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 63, Issue 3, Pages (March 2013)

Volume 56, Issue 1, Pages (July 2009)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 68, Issue 6, Pages e134-e135 (December 2015)

Volume 64, Issue 6, Pages (December 2013)

Volume 70, Issue 3, Pages e72-e74 (September 2016)

TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential Liang Cheng, Rodolfo Montironi,

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

2005 Update on Pathology of Prostate Biopsies with Cancer

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 54, Issue 6, Pages (December 2008)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 63, Issue 2, Pages (February 2013)

European Urology is “Your” Journal

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

The Start-Up of the Platinum Journal: A Fascinating Challenge

Volume 53, Issue 6, Pages (June 2008)

Volume 54, Issue 1, Pages (July 2008)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Pathological Findings in TRUS Prostatic Biopsy—Diagnostic, Prognostic and Therapeutic Importance Rodolfo Montironi, Roberta Mazzucchelli, Vincenzo Scattoni,

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

2005 Update on Pathology of Prostate Biopsies with Cancer

Presentation transcript:

Volume 66, Issue 6, Pages 1190-1193 (December 2014) Re: Antibody-drug Conjugates Targeting Prostate-specific Membrane Antigen Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli, Roberta Mazzucchelli, Francesco Montorsi European Urology Volume 66, Issue 6, Pages 1190-1193 (December 2014) DOI: 10.1016/j.eururo.2014.08.047 Copyright © 2014 Terms and Conditions

Fig. 1 (a) Strong and diffuse prostate-specific antigen (PSA) immunostaining in a Gleason 3+3=6 acinar adenocarcinoma; (b) lack of PSA immunostaining in the bone metastasis of a solid prostate cancer (this represents the progression stage of the patient whose initial adenocarcinoma is shown in (a); (c) weak and focal prostate-specific membrane antigen (PSMA) immunostaining (the same tumor as in [a]); (d) strong and diffuse PSMA immunostaining, mostly at the cell membrane level (the same tumor as in [b]). European Urology 2014 66, 1190-1193DOI: (10.1016/j.eururo.2014.08.047) Copyright © 2014 Terms and Conditions